GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Sale Of Investment

Biofarm (BSE:BIO) Sale Of Investment : lei0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm Sale Of Investment?

Biofarm's sale of investment for the three months ended in Dec. 2024 was lei0.0 Mil. It means Biofarm gained lei0.0 Mil from selling investments. Biofarm's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was lei0.0 Mil.

Compared with last quarter (lei0.0 Mil in Sep. 2024 ), Biofarm gained the same money from selling investments in Dec. 2024 (lei0.0 Mil).

Biofarm Sale Of Investment Historical Data

The historical data trend for Biofarm's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Sale Of Investment Chart

Biofarm Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 21.00 - - -

Biofarm Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biofarm Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Biofarm's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofarm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Sale Of Investment
Comparable Companies
BSE:ATB ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904 NBIX
Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Website
https://www.biofarm.ro
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.